| Gunnison Valley Hospital | |
|
85 N 100 E Ste A Gunnison UT 84634-7720 | |
| (435) 528-7202 | |
| (435) 528-3624 |
| Full Name | Gunnison Valley Hospital |
|---|---|
| Speciality | Family Medicine |
| Location | 85 N 100 E Ste A, Gunnison, Utah |
| Authorized Official Name and Position | Brian C. Murray (CFO) |
| Authorized Official Contact | 4355282146 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Gunnison Valley Hospital Po Box 759 Gunnison UT 84634-0759 Ph: (435) 528-7202 | Gunnison Valley Hospital 85 N 100 E Ste A Gunnison UT 84634-7720 Ph: (435) 528-7202 |
| NPI Number | 1255924486 |
|---|---|
| Provider Enumeration Date | 02/18/2021 |
| Last Update Date | 02/18/2021 |
| Medicare PECOS PAC ID | 3678487659 |
|---|---|
| Medicare Enrollment ID | O20031113000860 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255924486 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Bradford Kelly Ence |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1588766299 PECOS PAC ID: 8224078696 Enrollment ID: I20050504001103 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Gerald James Willden |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1043362049 PECOS PAC ID: 0749206902 Enrollment ID: I20051018000618 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Sean L Olsen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609235688 PECOS PAC ID: 5597063396 Enrollment ID: I20160412000798 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Sean Jay Henderson |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1366753709 PECOS PAC ID: 5597086280 Enrollment ID: I20160713002253 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Kyle Comin |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1215362876 PECOS PAC ID: 1254561129 Enrollment ID: I20180125001842 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Britney Bunot |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1821423609 PECOS PAC ID: 6002151693 Enrollment ID: I20190102000244 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Bryce Alden Barton |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1629631825 PECOS PAC ID: 6709299928 Enrollment ID: I20210107002616 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Joshua Truman Chapman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790378917 PECOS PAC ID: 4082021514 Enrollment ID: I20210330002514 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Ryan T Eddins |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1902262553 PECOS PAC ID: 8527453604 Enrollment ID: I20220329000229 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
| Provider Name | Kayla Olson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306504246 PECOS PAC ID: 5193104099 Enrollment ID: I20220623002181 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The higher risk of schizophrenia among offspring of expectant mothers living through famine could help us understand the genetic basis for that debilitating mental disorder.
Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.
"After fourteen years of being stuck in Congress, legislators in the Philippines finally put to a historic vote and passed the Reproductive Health Bill before dawn Thursday," Inquirer.net reports.
The U.S. Veterans Health Administration (VHA) has awarded Sperian Respiratory Protection USA a contract to purchase 65,000 special configuration modified Sperian Blue1 half-mask respirators with speaking diaphragm for use in VHA hospitals nationwide. VHA is the largest integrated healthcare system in the United States with over 150 hospitals and 130,000 healthcare workers. This award is a result of Sperian's emphasis on developing respiratory products that enhance speech intelligibility when worn by healthcare workers.
› Verified 4 days ago
Scott J. Walker, Do Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-2186 | |
Gunnison Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-7291 Fax: 435-528-3844 | |
Kimberly E Beck Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 76 East Center, Gunnison, UT 84634 Phone: 435-528-7935 Fax: 435-528-7936 | |
Gunnison Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 64 East 100 North, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-7796 |